A study of the epidemiology of sepsis revealed that the annual number of cases of sepsis caused by fungal organisms increased 207% between 1979 207% between and 2000 207% between (Zaoutis et al., 2005 . The increase in invasive fungal infections is related to more people receiving immunosuppressive therapy for hematologic malignancies, allogeneic hematopoietic stem cell transplantation, and broad-spectrum antibiotics. Invasive therapies such as central venous catheterization, mechanical ventilation, parenteral nutrition, and gastrointestinal procedures also have contributed to an increase in fungal infections.
Candidiasis
Candida species are the leading cause of invasive fungal infections in hospitalized patients and the fourth most common isolate recovered from cases of nosocomial blood stream infections in the United States. Recent data from the Surveillance and Control of Pathogens Epidemiologic System regarding nosocomial bloodstream infections in U.S. hospitals identifi ed a crude mortality rate of 40% for nosocomial candidemia, with 38% of the deaths directly attributable to the underlying disease (Wenzel & Edmond, 2001) .
Most bloodstream infections with Candida species are caused by Candida albicans, Candida glabrata, Candida tropicalis, or Candida parapsilosis (Fridkin, 2005) . The remaining infections tend to be caused by Candida krusei, Candida lusitaniae, or Candida guilliermondii. All four of the major species produce biofi lms that can form on central venous catheters. Antifungal drugs have a reduced ability to penetrate the biofi lms and eradicate the organisms. Candida parapsilosis also can colonize skin, leading to nosocomial spread by the hands and persistence in hospital environments.
Candida infections often involve disease outside the bloodstream. For example, disease may spread from the gastrointestinal tract to catheters and then to other organs. Patients with hepatosplenic candidiasis will be febrile and have abdominal pain and hepatosplenomegaly. Serum alkaline phosphatase levels usually are elevated greatly, disproportionately to other liver function tests. Hepatosplenic candidiasis can be diagnosed by CT scan or magnetic resonance imaging of the abdomen, which reveals multiple lesions in the liver or spleen. Treatment for the infection requires two to three weeks of therapy before patients show any response. The use of prophylactic fl uconazole has greatly reduced the incidence of hepatosplenic candidiasis. Pulmonary nodules also can be detected by CT scan, and fungal skin lesions can be diagnosed by skin biopsy.
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